| Literature DB >> 27563406 |
Zongxing Qiu1, Bernd Kuhn2, Johannes Aebi2, Xianfeng Lin1, Haiyuan Ding1, Zheng Zhou1, Zhiheng Xu1, Danqing Xu1, Li Han1, Cheng Liu1, Hongxia Qiu1, Yuxia Zhang1, Wolfgang Haap2, Claus Riemer2, Martin Stahl2, Ning Qin1, Hong C Shen1, Guozhi Tang1.
Abstract
ATG4B or autophagin-1 is a cysteine protease that cleaves ATG8 family proteins. ATG4B plays essential roles in the autophagosome formation and the autophagy pathway. Herein we disclose the design and structural modifications of a series of fluoromethylketone (FMK)-based peptidomimetics as highly potent ATG4B inhibitors. Their structure-activity relationship (SAR) and protease selectivity are also discussed.Entities:
Keywords: ATG4B; autophagy; covalent inhibitor; fluoromethylketone; peptidomimetics
Year: 2016 PMID: 27563406 PMCID: PMC4983731 DOI: 10.1021/acsmedchemlett.6b00208
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345